MedImmune Ventures, Inc.'s Net Worth

$68.7 Million

Who is MedImmune Ventures, Inc.?

MedImmune Ventures, Inc. has an estimated net worth of $68.7 Million. This is based on reported shares across multiple companies, which include INOTEK PHARMACEUTICALS CORP, G1 Therapeutics, Inc., APPLIED GENETIC TECHNOLOGIES CORP, CATABASIS PHARMACEUTICALS INC, and CRITICAL THERAPEUTICS INC.

SEC CIK

MedImmune Ventures, Inc.'s CIK is 0001291884

Past Insider Trading and Trends

2014 was MedImmune Ventures, Inc.'s most active year for acquiring shares with 3 total transactions. MedImmune Ventures, Inc.'s most active month to acquire stocks was the month of May. 2017 was MedImmune Ventures, Inc.'s most active year for disposing of shares, totalling 6 transactions. MedImmune Ventures, Inc.'s most active month to dispose stocks was the month of March. 2015 saw MedImmune Ventures, Inc. paying a total of $2,681,268.00 for 1,632,652 shares, this is the most they've acquired in one year. In 2017 MedImmune Ventures, Inc. cashed out on 10,762,519 shares for a total of $10,596,643.50, their largest year based on trade value.